Method for treating Philadelphia-negative myeloproliferative syndromes
- 专利权人:
- Paolo Mascagni
- 发明人:
- Paolo Mascagni,Carmine Durzo,Joseê Golay
- 申请号：
- US12662004
- 公开号：
- US08217079B2
- 申请日:
- 2010.03.26
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- Method for treating Philadelphia-negative myeloproliferative syndromes in a patient in need of such treatment, by administering to the patient diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof, in combination with N-hydroxyurea.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of histone deacetylase inhibitors for the treatment of Philadelphia negative myeloproliferative syndromes
- CHLORURE DE DIETHYL-[6-(4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL)-NAPHTALENE -2-YL-METHYL]AMMONIUM POUR UNE UTILISATION DANS LE TRAITEMENT DE LA DYSTROPHIE MUSCULAIRE
- Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy
- diethyl- [6- (4-hydroxycarbamoyl-phenylcarbamoyloxy-methyl) -naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy
- Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy
